Answer
Pemigatinib inhibits P-gp in vitro and may increase exposure to digoxin, a P-gp substrate, thereby increasing its toxicity.
Sources for this answer
- Pemazyre 4.5 mg - tabletsIncyte Biosciences UK Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 5Document updated
Sources checked